Related Experiment Video
Updated: Jun 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality
Evangelos N Liberopoulos1, Matilda Florentin, Dimitri P Mikhailidis
1University of Ioannina, Medical School, Department of Internal Medicine, Ioannina, Greece.
Insights
Poor adherence to cholesterol-lowering drugs is common, impacting cardiovascular health. Improving patient compliance with statin therapy is crucial for better clinical outcomes and reducing cardiovascular events.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypercholesterolemia is a significant risk factor for cardiovascular disease.
- Lipid-lowering agents reduce vascular event risk in primary and secondary prevention.
Purpose of the Study:
- To review the issue of physician attention to patient compliance with lipid-lowering therapy.
- To highlight the impact of compliance on cardiovascular clinical outcomes.
Main Methods:
- Literature search conducted using PubMed up to August 5, 2008.
Main Results:
- Compliance with lipid-lowering therapy, particularly statins, is poor in clinical practice.
- Approximately 60% of patients discontinue statins within six months.
- Poor compliance is linked to worse clinical outcomes, increased cardiovascular morbidity, and mortality.
Conclusions:
- Low adherence to lipid-lowering treatment is a critical health concern associated with adverse cardiovascular outcomes.
- Physicians must prioritize strategies to enhance patient adherence to lipid-lowering therapies.
Background:
Hypercholesterolemia is a major risk factor for cardiovascular disease.
Objective:
Treatment with hypolipidemic agents reduces the risk of vascular events both in primary and secondary prevention. Although compliance with lipid-lowering therapy is an important determinant of cardiovascular clinical outcomes, relatively little attention is being paid to this issue by physicians.
Methods:
We searched the literature using Pubmed up to 5 August 2008.
Results:
Compliance with lipid-lowering therapy is poor in clinical practice, especially in primary prevention. As many as 6 out of 10 patients may stop taking statins during the first 6 months following initiation of treatment. Poor compliance has been associated with worse clinical outcome and increased cardiovascular morbidity and mortality. Importantly, statin withdrawal may be even worse compared with not taking statins at all. Several strategies may increase treatment adherence.
Conclusions:
Poor compliance with lipid-lowering treatment is an important health issue that has been associated with unfavorable cardiovascular outcome. Increasing adherence rates should become a major concern for physicians.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...